China · Delayed Price · Currency is CNY Zhende Medical Statistics
Total Valuation
Zhende Medical has a market cap or net worth of CNY 21.56 billion. The enterprise value is 22.19 billion.
| Market Cap | 21.56B |
| Enterprise Value | 22.19B |
Important Dates
The last earnings date was Friday, August 28, 2026.
| Earnings Date | Aug 28, 2026 |
| Ex-Dividend Date | Jun 18, 2026 |
Share Statistics
Zhende Medical has 263.75 million shares outstanding. The number of shares has decreased by -0.37% in one year.
| Current Share Class | 263.75M |
| Shares Outstanding | 263.75M |
| Shares Change (YoY) | -0.37% |
| Shares Change (QoQ) | -4.40% |
| Owned by Insiders (%) | 10.52% |
| Owned by Institutions (%) | 4.04% |
| Float | 102.36M |
Valuation Ratios
The trailing PE ratio is 77.79 and the forward PE ratio is 43.94.
| PE Ratio | 77.79 |
| Forward PE | 43.94 |
| PS Ratio | 4.84 |
| PB Ratio | 3.63 |
| P/TBV Ratio | 5.46 |
| P/FCF Ratio | 586.36 |
| P/OCF Ratio | 51.00 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 33.15, with an EV/FCF ratio of 603.54.
| EV / Earnings | 80.15 |
| EV / Sales | 4.98 |
| EV / EBITDA | 33.15 |
| EV / EBIT | 63.44 |
| EV / FCF | 603.54 |
Financial Position
The company has a current ratio of 1.66, with a Debt / Equity ratio of 0.22.
| Current Ratio | 1.66 |
| Quick Ratio | 1.02 |
| Debt / Equity | 0.22 |
| Debt / EBITDA | 1.98 |
| Debt / FCF | 36.13 |
| Interest Coverage | 11.11 |
Financial Efficiency
Return on equity (ROE) is 4.85% and return on invested capital (ROIC) is 4.72%.
| Return on Equity (ROE) | 4.85% |
| Return on Assets (ROA) | 2.61% |
| Return on Invested Capital (ROIC) | 4.72% |
| Return on Capital Employed (ROCE) | 5.31% |
| Weighted Average Cost of Capital (WACC) | 6.27% |
| Revenue Per Employee | 563,088 |
| Profits Per Employee | 35,002 |
| Employee Count | 7,909 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 3.58 |
Taxes
In the past 12 months, Zhende Medical has paid 52.97 million in taxes.
| Income Tax | 52.97M |
| Effective Tax Rate | 15.56% |
Stock Price Statistics
The stock price has increased by +129.32% in the last 52 weeks. The beta is 0.41, so Zhende Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.41 |
| 52-Week Price Change | +129.32% |
| 50-Day Moving Average | 84.82 |
| 200-Day Moving Average | 83.37 |
| Relative Strength Index (RSI) | 46.24 |
| Average Volume (20 Days) | 1,423,383 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Zhende Medical had revenue of CNY 4.45 billion and earned 276.83 million in profits. Earnings per share was 1.05.
| Revenue | 4.45B |
| Gross Profit | 1.48B |
| Operating Income | 349.75M |
| Pretax Income | 340.47M |
| Net Income | 276.83M |
| EBITDA | 658.01M |
| EBIT | 349.75M |
| Earnings Per Share (EPS) | 1.05 |
Balance Sheet
The company has 960.74 million in cash and 1.33 billion in debt, with a net cash position of -367.49 million or -1.39 per share.
| Cash & Cash Equivalents | 960.74M |
| Total Debt | 1.33B |
| Net Cash | -367.49M |
| Net Cash Per Share | -1.39 |
| Equity (Book Value) | 5.94B |
| Book Value Per Share | 21.81 |
| Working Capital | 1.15B |
Cash Flow
In the last 12 months, operating cash flow was 422.68 million and capital expenditures -385.92 million, giving a free cash flow of 36.76 million.
| Operating Cash Flow | 422.68M |
| Capital Expenditures | -385.92M |
| Depreciation & Amortization | 308.26M |
| Net Borrowing | -168.98M |
| Free Cash Flow | 36.76M |
| FCF Per Share | 0.14 |
Margins
Gross margin is 33.28%, with operating and profit margins of 7.85% and 6.22%.
| Gross Margin | 33.28% |
| Operating Margin | 7.85% |
| Pretax Margin | 7.65% |
| Profit Margin | 6.22% |
| EBITDA Margin | 14.78% |
| EBIT Margin | 7.85% |
| FCF Margin | 0.83% |
Dividends & Yields
This stock pays an annual dividend of 0.30, which amounts to a dividend yield of 0.37%.
| Dividend Per Share | 0.30 |
| Dividend Yield | 0.37% |
| Dividend Growth (YoY) | -53.85% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 41.08% |
| Buyback Yield | 0.37% |
| Shareholder Yield | 0.74% |
| Earnings Yield | 1.28% |
| FCF Yield | 0.17% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 8, 2020. It was a forward split with a ratio of 1.4.
| Last Split Date | Jun 8, 2020 |
| Split Type | Forward |
| Split Ratio | 1.4 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |